Morbid obesity
Conditions
Interventions
None listed
Sponsors
Kusatsu General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Morbid obesity individuals with BMI 35 or higher with or without diabetes mellitus For surgical treatment group, patients who underwent laparoscopic sleeve gastrectomy using public health insurance
Exclusion criteria
Exclusion criteria: Treatable secondary obese patients. Pregnant women or patients who may be pregnant. Patients who can not obtain written consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medical expenses for 2 years from registration Patient's background at registration, and QOL survey (SF-36 and EQ-5D) every 3 months for 2 years after registration. Metabolic indicators (HbA1c, presence and content of medication including antidiabetics and insulin, BMI, C peptide, history of diabetes mellitus etc.), SBP/DBP, HR, AST, ALT, TCHO, HDL, LDL, TG, UA, Cre etc. every 6 months for 2 years after registration. | — |
Countries
Japan
Contacts
Public ContactHiroshi Yamamoto
Kusatsu General Hospital Department of Gastrointestinal Surgery
Outcome results
None listed